Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Bausch + Lomb Corporation Common Shares (NY:BLCO)

11.50 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 11.50
Bid (Size) 11.39 (15)
Ask (Size) 11.79 (3)
Prev. Close 11.50
Today's Range 11.50 - 11.50
52wk Range 10.45 - 21.69
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1 Safe-and-Steady Stock for Long-Term Investors and 2 to Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-36.1%
-36.1%
1 Month
-15.8%
-15.8%
3 Month
-27.3%
-27.3%
6 Month
-41.5%
-41.5%
1 Year
-25.0%
-25.0%

More News

Read More
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
Via Benzinga
Exposures Product Safety
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
From Bausch + Lomb Corporation
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
Via Benzinga
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States
From Bausch + Lomb Corporation
Via Business Wire
BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty
Via StockStory
Topics World Trade
Exposures Tariff
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
3 Profitable Stocks Walking a Fine Line
Via StockStory
Topics Economy Supply Chain
Exposures Coal Supply Chain
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
From Bausch + Lomb Corporation
Via Business Wire
Why Bausch + Lomb (BLCO) Shares Are Falling Today
Via StockStory
Topics Initial Public Offering
Exposures Securities Market
Wednesday's session: gap up and gap down stocks
Via Chartmill
Starbucks Posts Weak Earnings, Joins Super Micro Computer, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Bausch + Lomb (NYSE:BLCO) Misses Q1 Sales Targets, Stock Drops 10.4%
Via StockStory
Bausch + Lomb Announces First-Quarter 2025 Results
From Bausch + Lomb Corporation
Via Business Wire

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 11.50
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 06/03/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.